Berkshire shareholders like Greg Abel, but following Warren Buffett is tough
Berkshire shareholders like Greg Abel, but following Warren Buffett is tough
Source link
Similar Posts
Blog Post: Day 41 of $QQQ short term down-trend; $QQQ finishing Stage 3 and may begin Stage 4 decline; I never fight the market’s trend. Only young people can wait out a decline and recovery. I believe that Boomers belong on the sidelines, protecting their hard earned savings and investments.
QQQ’s 10 week average remains below the 30 wk average and the 30 week average is flat. If the 30 week should begin a decline, it will give the stage 4 signal that occurs at the beginning of a major decline. Last week, QQQ retraced to its 4 week average, as expected. I am mostly…
TFSA: 2 Canadian Stocks I’d Happily Buy and Hold for Life
The optimum use of a Tax-Free Savings Account (TFSA) happens when you invest in growth stocks for the long term. Capital gains taxes reduce the investment income from the sale of stocks. However, investing through the TFSA can help you avoid capital gain tax, with its special tax treatment. Hence, this account needs growth stocks…
Gokaldas Exports Falls 3% on Bangladesh Tariff Cut
August 1, 2025August 1, 2025 Shares of Gokaldas Exports Ltd fell nearly 3% after touching a day’s high of Rs 859.95 on 1st August, following the announcement of the latest tariff developments by the US administration under President Donald Trump. Pearl Global Ltd, Arvind Ltd, and Welspun Living Ltd…
OMCs, paint, aviation stocks in focus on oil prices decline amid growth concerns, higher OPEC+ supply
The shares of oil paint, aviation and oil marketing companies (OMCs) may remain in focus today amid weakening crude prices and the decision by OPEC+ to ramp up output. Crude oil prices have dropped sharply—plunging nearly $10 per barrel in a week—after the Trump administration announced new tariffs on select countries, sparking demand concerns, even…
No Coincidence
Source link
Trump to Hit Patented Drugs with a 100% Tariff
April 3, 2026April 3, 2026 The Trump administration has proposed a broad tariff structure that targets copyrighted pharmaceutical products while providing short-term assistance to generic drugmakers. A 100% tariff on patented pharmaceutical items has been suggested, with implementation timetables of 120 days for large corporations and 180 days for…
